2.761 -0.029 (-1.04%) | 06-28 09:48 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 4.08 | 1-year : | 4.9 |
Resists | First : | 3.49 | Second : | 4.19 |
Pivot price | 2.84 | |||
Supports | First : | 2.34 | Second : | 1.95 |
MAs | MA(5) : | 2.93 | MA(20) : | 0 |
MA(100) : | 0 | MA(250) : | 0 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 47.3 | D(3) : | 0 |
RSI | RSI(14): 42.6 | |||
52-week | High : | 3.24 | Low : | 2.34 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KDLY ] has closed above bottom band by 30.1%. Bollinger Bands are 0% narrower than normal.
If tomorrow: | Open lower | Open higher |
High: | 3.09 - 3.11 | 3.11 - 3.12 |
Low: | 2.7 - 2.72 | 2.72 - 2.74 |
Close: | 2.76 - 2.79 | 2.79 - 2.82 |
Fri, 28 Jun 2024
KindlyMD Announces First Quarter 2024 Financial Results and Provides Shareholder Update - StockTitan
Mon, 10 Jun 2024
Here's How To Enhance Marijuana Therapies: KindlyMD And Curaleaf Collab Provide More Resources And ... - Quantisnow
Fri, 31 May 2024
WallachBeth Capital Announces Pricing of KindlyMD's $6.8 Million IPO - PR Newswire
Mon, 20 May 2024
IPO roundup: KDLY, BOW, and more (Pending:BOW) - Seeking Alpha
Mon, 13 May 2024
Kindly MD Finalizes Micro IPO Terms (NASDAQ:KDLY) - Seeking Alpha
Wed, 20 Sep 2023
Medical cannabis treatment data company Kindly MD files for IPO - MarketWatch
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 6 (M) |
Held by Insiders | 1.9e+006 (%) |
Held by Institutions | 116 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | -1.51e+006 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | -43 % |
Operating Margin | -39.8 % |
Return on Assets (ttm) | -99 % |
Return on Equity (ttm) | -1 % |
Qtrly Rev. Growth | 3.77e+006 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |